Want to join the conversation?
The biotechnology company $CELG reported a 3Q15 loss due to higher costs on Juno Therapeutics collaboration and expenses on purchase of Receptos. Net loss was $34.1MM or $0.04 per share compared to a profit of $508.5MM or $0.61 per share last year. Revenue grew to $2.33Bil from $1.98Bil. Adjusted EPS rose to $1.23 from $0.97.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!